RSNA 2009 

Abstract Archives of the RSNA, 2009


SSQ15-03

Factors Associated with False Negative Results in MIBI Parathyroid Scintigraphy

Scientific Papers

Presented on December 3, 2009
Presented as part of SSQ15: ISP:  Nuclear Medicine (Endocrine and Neuroendocrine Imaging)

Participants

Kenneth Nichols PhD, Presenter: Royalties, Syntermed, Inc
Maria Bernadette Tomas MD, Abstract Co-Author: Nothing to Disclose
Gene Gellegani Tronco MD, Abstract Co-Author: Nothing to Disclose
Christopher J. Palestro MD, Abstract Co-Author: Research grant, General Electric Company

PURPOSE

To identify factors associated with false negative (FN) MIBI studies in pts with primary hyperparathyroidism (PHP).

METHOD AND MATERIALS

This was a retrospective investigation of 659 pts with biochemically confirmed PHP who underwent preoperative parathyroid lesion localization using a dual tracer 99mTc-MIBI/99mTcO4- protocol that included early & late planar pinhole 99mTc-MIBI, pinhole thyroid imaging, image subtraction, & SPECT. All pts subsequently underwent surgery. Pathology reports were reviewed for lesion weights & histology: adenoma (A) or hypercellular, and/or enlarged, and/or fat depleted, but not an adenoma (nonA). One experienced nuclear physician, who had no knowledge of other test results or final diagnoses graded studies on a 5-point scale (0=definitely normal to 4=definitely abnormal) while reading all scintigraphic images simultaneously. Association of false negative results with patient age, sex, lesion weight, lesion location, pre-surgical PTH & Ca levels & cell type (A or nonA) were evaluated by logistic regression.

RESULTS

There were 859 lesions among the 659 pts. 528 pts (80%) had single gland disease (SGD); 131 (20%) had multigland disease (MGD) (74 pts had 2 lesions, 45 had 3, & 12 had 4 lesions). 261 (30%) lesions were A; 598 (70%) were nonA. 45% of SGD lesions were A; 7.5% of MGD lesions were A (p < 0.0001). The factor most strongly associated with a FN result was MGD (Χ2 = 330.7; p<0.0001), followed by lesion weight (Χ2 = 51.3; p<0.0001), nonA histology (Χ2 = 11.5; p=0.0007), & elevated Ca level (Χ2 = 5.8; p=0.02). Age, sex, lesion location & PTH levels were too weakly predictive to permit computing an association. Scintigraphy was significantly more sensitive for SGD than for MGD (96% versus 61%, p<0.0001), with lesions of greater weight (log(weight) = -0.62±1.07 versus -1.55±1.16, p<0.0001) & marginally higher calcium levels (11.2±3.5 versus 10.9±1.0, p=0.042). Scintigraphy was most sensitive for detecting SGD A lesions (FN = 1%), & least sensitive for detecting MGD nonA lesions (FN = 41%).

CONCLUSION

While several factors are associated with false negative MIBI parathyroid studies in PHP, multigland disease is the single most strongly associated parameter.

CLINICAL RELEVANCE/APPLICATION

Because of lower test sensitivity for MGD, preoperative MIBI imaging alone is insufficient & must be used along with rapid intraoperative parathyroid hormone assay to assure removal of all lesions.

Cite This Abstract

Nichols, K, Tomas, M, Tronco, G, Palestro, C, Factors Associated with False Negative Results in MIBI Parathyroid Scintigraphy.  Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8004714.html